Plasma Levels of Soluble FCγ Receptors II (sCD32) and III (sCD16) in Patients with Heparin-induced Thrombocytopenia

R Saffroy; C Bachelot-Loza; W H Fridman; M Aiach; J-L Teillaud; F Rendu

doi:10.1055/s-0038-1657669

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1997; 78(02): 970-971
DOI: 10.1055/s-0038-1657669

Letter to the Editor

Schattauer GmbH Stuttgart

Plasma Levels of Soluble FC_γ Receptors II (sCD32) and III (sCD16) in Patients with Heparin-induced Thrombocytopenia

Authors

R Saffroy

¹INSERM U. 428, Faculté de Pharmacie, PARIS V, Paris, France
C Bachelot-Loza

¹INSERM U. 428, Faculté de Pharmacie, PARIS V, Paris, France
W H Fridman

²INSERM U. 255, Institut Curie, Paris, France
M Aiach

¹INSERM U. 428, Faculté de Pharmacie, PARIS V, Paris, France
J-L Teillaud

²INSERM U. 255, Institut Curie, Paris, France
F Rendu

¹INSERM U. 428, Faculté de Pharmacie, PARIS V, Paris, France

Abstract

als PDF herunterladen

PDF (441 kb)

Referenzen

References
1 Amiral J, Bridey F, Dreyfus M, Vissac AM, Fressinaud E, Wolf M, Meyer D. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost 1992; 68: 95-96
2 Kelton JG, Sheridan D, Santos A, Smith J, Steves K, Smith C, Brown C, Murphy WG. Heparin-induced thrombocytopenia: laboratory studies. Blood 1988; 72: 925-930
3 Cassel DL, Keller MA, Surrey S, Schwartz E, Schreiber AD, Rapaport EF, McKenzie SE. Differential expression of FC7RIIA, FC7RIIB and FC7RIIC in hematopoietic cells. Analysis of transcripts. Mol Immunol 1993; 30: 451-460
4 Khayat D, Geffrier C, Yoon S, Scigliano E, Soubrane C, Weil M, Unkeless JC, Jacquillat C. Soluble circulating FC7 receptors in human serum: a new ELISA assay for specific and quantitative detection. J Immunol Meth 1987; 100: 235-241
5 Fridman WH, Mathiot C, Moncuit J, Teillaud JL. Fc receptors, immunoglobulin-binding factors and B chronic lymphocytic leukemia. Nouv Rev Franc Hematol 1988; 30: 311-315
6 Huizinga TWJ, De HaasM, Kleijer M, Nuijens JH, Roos D, von demBorne AEGK. Soluble FC7 receptor III in human plasma originates from release by neutrophils. J Clin Invest 1990; 86: 416-423
7 Lanier LL, Phillips JH, Testi R. Membrane anchoring and spontaneous release of CD 16 (FcRIII) by natural killer cells and granulocytes. Eur J Immunol 1989; 19: 775-778
8 Astier A, de laSalle H, Moncuit J, Freund M, Cazenave JP, Fridman WH, Hanau D, Teillaud JL. Detection and quantification of secreted soluble FC7RIIA in human sera by an enzyme-linked immunosorbent assay. J Immunol Methods 1993; 166: 01-10
9 Teillaud JL, Bouchard C, Astier A, Teillaud C, Tartour E, Michon J, Galinha A, Moncuit J, Mazieres N, Spagnoli R, Fridman WH, Sautes C. Natural and recombinant soluble low-affmity FC7R: detection, purification, and functional activities. Immunomethods 1994; 04: 48-64
10 Rapaport EF, Cassel DL, Walterhouse DO, McKenzie SE, Surrey S, Keller MA, Schreiber AD, Schwartz E. A soluble form of the human Fc receptor FC7RIIA: Cloning, transcript analysis and detection. Exp Haematol 1993; 21: 689-696
11 Gachet C, Astier A, de laSalle H, de laSalle C, Fridman WH, Cazenave JP, Hanau D, Teillaud JL. Release of Fc7RHa2 by activated platelets and inhibition of anti-CD9-mediated platelet aggregation by recombinant Fc7RIIa2. Blood 1995; 8: 698-704
12 Sheridan D, Carter C, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia. Blood 1986; 67: 27-30